everi
year
influenza
season
togeth
two
subtyp
influenza
viru
two
lineag
influenza
b
virus
simultan
circul
year
respons
major
diseas
burden
unlik
influenza
virus
human
sole
host
epidemiolog
relev
influenza
b
virus
explain
antigen
shift
occur
virus
abl
caus
pandem
howev
influenza
b
virus
evolv
mainli
genet
reassort
strain
differ
lineag
allow
escap
host
immun
preserv
abil
caus
diseas
regardless
lineag
influenza
b
infect
caus
sever
diseas
death
mani
year
vaccin
administr
demonstr
best
solut
reduc
influenza
diseas
burden
human
howev
past
recommend
vaccin
includ
one
influenza
b
lineag
chosen
world
health
organ
base
surveil
data
use
lineag
observ
domin
previou
year
recent
quadrival
vaccin
contain
influenza
b
lineag
prepar
licens
countri
howev
mainli
increas
cost
vaccin
trival
vaccin
still
commonli
use
worldwid
presum
preval
given
influenza
b
lineag
may
driven
viru
contain
trival
vaccin
introduct
quadrival
prepar
may
reduc
select
pressur
respons
modif
lineag
preval
howev
rel
common
emerg
influenza
b
reassort
suggest
strict
monitor
genet
characterist
circul
strain
necessari
order
assur
best
select
b
virus
includ
influenza
vaccin
primari
aim
studi
evalu
molecular
characterist
influenza
b
virus
circul
region
northern
itali
lombardia
influenza
season
studi
carri
pediatr
high
intens
care
unit
fondazion
ircc
ca
granda
ospedal
maggior
policlinico
degli
studi
di
milano
milan
itali
pediatr
clinic
section
microbiolog
depart
clinic
surgic
diagnost
pediatr
scienc
univers
pavia
pavia
itali
decemb
march
institut
locat
lombardia
region
northern
itali
approxim
million
inhabit
nasopharyng
swab
subject
regardless
age
previou
diagnosi
underli
diseas
present
emerg
room
institut
sign
andor
symptom
influenzalik
ill
ili
accord
definit
italian
ministri
health
collect
analyz
respiratori
virus
includ
influenza
ili
acut
respiratori
diseas
sudden
onset
fever
temperatur
accompani
least
one
gener
symptom
ie
headach
gener
malais
feverish
sensat
sweat
chill
asthenia
least
one
respiratori
symptom
ie
cough
pharyngodynia
nasal
congest
respiratori
symptom
last
least
three
day
consid
analysi
one
newonset
ill
could
includ
twoweek
period
data
regard
influenza
vaccin
coverag
collect
parent
studi
approv
institut
review
board
fondazion
ircc
ca
granda
ospedal
maggior
policlinico
milan
itali
written
inform
consent
obtain
enrol
subject
children
inform
consent
sign
parent
legal
guardian
children
year
requir
give
written
assent
enter
studi
respiratori
sampl
extract
use
instrument
dsp
viruspathogen
midi
kit
complex
protocol
accord
manufactur
instruct
qiagen
qiagen
hilden
germani
panel
laboratorydevelop
realtim
rtpolymeras
chain
reaction
pcr
realtim
pcr
use
detect
quantifi
follow
virus
influenza
viru
b
includ
subtyp
determin
human
rhinoviru
hrv
human
parainfluenza
viru
hpiv
respiratori
syncyti
viru
rsv
type
b
human
coronaviru
hcov
human
metapneumoviru
hmpv
sampl
posit
influenza
b
analyz
molecular
character
entir
influenza
b
ha
gene
amplifi
directli
clinic
specimen
use
superscriptiii
onestep
rtpcr
amplif
kit
invitrogen
carlsbad
usa
primer
follow
cycl
condit
min
min
cycl
min
final
extens
cycl
min
two
seminest
pcr
perform
b
follow
cycl
condit
min
cycl
min
final
extens
cycl
min
purifi
pcr
product
sequenc
use
bigdy
termin
cyclesequenc
kit
appli
biosystem
foster
citi
usa
abi
prism
genet
analyz
appli
biosystem
foster
citi
usa
sequenc
assembl
use
sequench
softwar
version
gene
code
corpor
ann
arbor
usa
nucleotid
align
construct
use
clustalw
program
embed
mega
version
softwar
phylogenet
tree
gener
mean
maximum
likelihood
method
kimura
evolutionari
model
use
mega
version
softwar
bootstrap
analysi
replic
perform
nucleotid
sequenc
identifi
studi
submit
genbank
databas
access
number
order
evalu
ha
evolut
due
immunolog
pressur
seri
probabilist
model
codon
substitut
use
detail
test
posit
select
conduct
use
singlelikelihood
ancestor
count
slac
fixedeffect
likelihood
fel
randomeffect
likelihood
rel
intern
branch
fixedeffect
likelihood
ifel
mixedeffect
model
evolut
meme
fast
unconstrain
bayesian
approxim
fubar
datamonkey
server
dnd
ratio
calcul
use
slac
fel
codonbas
maximum
likelihood
approach
slac
count
number
nonsynonym
chang
per
nonsynonym
site
dn
test
whether
significantli
differ
number
synonym
chang
per
synonym
site
ds
fel
estim
ratio
nonsynonym
synonym
chang
site
align
ifel
method
similar
fel
test
sitebysit
select
along
intern
branch
phylogeni
avoid
excess
falseposit
rate
site
slac
fel
ifel
meme
pvalu
fubar
posterior
probabl
accept
candid
select
total
children
male
median
age
year
age
rang
month
year
ili
enrol
nasopharyng
sampl
collect
obtain
sampl
milano
pavia
among
test
posit
influenza
virus
influenza
influenza
b
none
enrol
children
receiv
season
influenza
vaccin
prepar
season
total
influenza
b
strain
sequenc
nearli
complet
ha
gene
sequenc
perform
strain
partial
ha
sequenc
rang
nt
nt
avail
sequenc
data
obtain
patient
due
low
viral
load
residu
sampl
avail
overal
nucleotid
ident
analyz
ha
sequenc
refer
influenza
b
vaccin
strain
rang
maximum
nucleotid
amino
acid
chang
phylogenet
analysi
show
great
major
influenza
b
strain
fall
clade
defin
amino
acid
substitut
base
number
fig
howev
clade
remain
antigen
like
vaccin
strain
includ
quadrival
vaccin
note
three
strain
close
relat
old
influenza
b
strain
circul
previou
season
two
character
mutat
also
observ
anoth
italian
influenza
b
strain
circul
period
strain
character
mutat
fig
studi
influenza
b
strain
seri
amino
acid
chang
observ
tabl
howev
amino
acid
chang
observ
ha
region
involv
receptor
bind
antibodi
recognit
loop
posit
loop
loop
helix
fig
detail
harbor
substitut
strain
character
differ
amino
acid
chang
highlight
red
fig
interestingli
chang
led
loss
glycosyl
site
near
receptorbind
region
global
analysi
select
pressur
made
use
slac
model
indic
estim
overal
dnd
ratio
total
codon
observ
least
one
amino
acid
chang
compar
vaccin
strain
overal
site
identifi
posit
select
sitespecif
analys
influenza
b
align
least
three
method
use
slac
fel
rel
fubar
meme
tabl
ifel
model
use
determin
select
pressur
act
codon
along
intern
branch
tree
identifi
posit
select
codon
influenza
b
sequenc
tabl
fact
chang
observ
six
influenza
b
strain
four
cluster
togeth
separ
branch
tree
shown
fig
contrast
seri
neg
select
site
identifi
tabl
nearli
half
within
region
strictli
correl
surfac
exposit
studi
enrol
children
ili
winter
season
sever
respiratori
virus
circul
preschool
children
enrol
studi
highli
suscept
infecti
agent
clinic
manifest
quit
similar
influenza
consequ
rel
low
percentag
patient
laboratorydocu
influenza
surpris
hand
influenza
season
preval
influenza
among
children
age
year
itali
calcul
valu
quit
similar
found
studi
antigen
character
influenza
b
strain
import
assess
similar
refer
virus
circul
virus
addit
character
also
use
annual
recommend
influenza
strain
includ
vaccin
northern
hemispher
base
phylogenet
data
influenza
b
strain
circul
two
children
hospit
belong
clade
within
bvictorialineag
find
similar
epidemiolog
scenario
observ
last
influenza
season
sentinel
sourc
european
center
diseas
control
ecdc
italian
nation
influenza
center
report
incid
respect
strain
belong
bvictorialineag
unfortun
season
bvictorialineag
strain
includ
trival
vaccin
licens
northern
hemispher
worldwid
accord
recommend
viru
byamagata
lineag
includ
therefor
find
could
reason
high
circul
bvictorialineag
strain
itali
well
throughout
european
countri
data
collect
ecdc
clearli
indic
besid
itali
also
belgium
franc
luxembourg
b
viru
predomin
caus
influenza
whole
itali
preval
b
influenza
viru
valu
substanti
differ
found
studi
base
epidemiolog
data
chang
recommend
influenza
trival
vaccin
composit
northern
hemispher
contrast
use
quadrival
vaccin
contain
two
influenza
b
strain
could
reduc
mismatch
vaccin
circul
influenza
strain
although
quadrival
influenza
vaccin
licens
itali
subject
year
use
still
restrict
mainli
definit
establish
introduct
expens
vaccin
realli
costeffect
among
detect
b
strain
three
character
differ
pattern
mutat
two
harbor
mutat
one
strain
harbor
mutat
strain
belong
two
three
subclad
previous
describ
circul
australia
detail
report
barr
colleagu
time
recent
common
ancestor
calcul
three
subclad
summer
find
suggest
multipl
introduct
differ
influenza
b
strain
last
influenza
season
lombardi
region
evolut
influenza
b
viru
driven
mutat
membranedist
domain
specif
domain
helix
sever
mutat
observ
specif
region
great
major
characterist
circul
strain
ie
mutat
observ
influenza
strain
sporad
occurr
four
influenza
b
strain
loss
import
glycosyl
site
posit
observ
experiment
eggadapt
influenza
b
variant
absenc
glycan
residu
observ
fact
influenza
viru
variant
observ
grow
better
chicken
egg
mammalian
viru
variant
origin
find
suggest
possibl
impact
loss
antibodi
recognit
vaccin
analysi
ratio
number
nonsynonym
synonym
substitut
per
site
dnd
reveal
lower
level
evolutionari
dynam
compar
influenza
howev
data
accord
recent
public
vijaykrishna
et
al
report
dnd
ratio
victorialineag
virus
overal
analysi
select
pressur
within
influenza
strain
sequenc
reveal
one
site
posit
select
seri
codon
purifi
select
find
suggest
moder
immun
select
victorialineag
influenza
b
viru
persist
circul
human
addit
also
shown
influenza
b
evolut
could
driven
posit
neg
select
moder
evolut
circul
influenza
b
strain
make
strain
antigen
similar
vaccin
strain
inde
sinc
season
influenza
b
vaccin
strain
chang
data
togeth
antigen
character
perform
ecdc
use
hemagglutinin
inhibit
hi
show
hi
reactiv
pattern
circul
influenza
b
strain
data
confirm
efficaci
influenza
vaccin
protect
influenza
b
circul
strain
howev
base
epidemiolog
data
studi
would
appropri
use
quadrival
instead
trival
vaccin
conclus
influenza
b
virus
circul
lombardi
region
itali
influenza
season
belong
influenza
b
victorialineag
includ
trival
vaccin
commonli
administ
influenza
season
itali
great
major
influenza
b
strain
similar
circul
europ
period
three
strain
close
relat
old
influenza
b
strain
circul
previou
season
find
indic
europ
particular
lombardi
region
itali
protect
influenza
b
infect
vaccin
subject
might
poor
period
introduct
quadrival
vaccin
italian
vaccin
campaign
could
prevent
reduc
circul
lineag
influenza
b
improv
protect
popul
potenti
sever
diseas
studi
approv
ethic
committe
fondazion
ircc
ca
granda
ospedal
maggior
policlinico
milan
itali
written
inform
consent
obtain
either
parent
legal
guardian
studi
particip
well
children
age
year
